We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Essential Utilities
WTRG
$11.2B
| $1.63M | 0.01% |
35,712
| – | – |
|
602
Ventas
VTR
$48.7B
| $1.63M | 0.01% |
28,538
-7,392
| -21% | -$413K |
|
603
Equifax
EFX
$20.8B
| $1.62M | 0.01% |
6,782
-745
| -10% | -$167K |
|
604
Teledyne Technologies
TDY
$30.2B
| $1.62M | 0.01% |
3,862
+1,028
| +36% | +$437K |
|
605
TransUnion
TRU
$14.9B
| $1.62M | 0.01% |
14,739
+2,650
| +22% | +$276K |
|
|
SIVB
606
DELISTED
SVB Financial Group
SIVB
| $1.62M | 0.01% |
2,907
-13,317
| -82% | -$7.39M |
|
607
Realty Income
O
$61.1B
| $1.61M | 0.01% |
24,937
+4,322
| +21% | +$284K |
|
608
Everest Group
EG
$15.4B
| $1.61M | 0.01% |
+6,396
| New | +$1.66M |
|
609
VeriSign
VRSN
$24.8B
| $1.61M | 0.01% |
7,060
+15
| +0.2% | +$3.27K |
|
610
Vulcan Materials
VMC
$36.9B
| $1.6M | 0.01% |
9,215
+411
| +5% | +$73.5K |
|
611
Ingersoll Rand
IR
$33.1B
| $1.6M | 0.01% |
32,769
+6,750
| +26% | +$331K |
|
612
Aldeyra Therapeutics
ALDX
$95.3M
| $1.59M | 0.01% |
+140,000
| New | +$1.68M |
|
|
ACHL
613
DELISTED
Achilles Therapeutics
ACHL
| $1.58M | 0.01% |
+161,624
| New | +$2.19M |
|
614
MongoDB
MDB
$24.9B
| $1.58M | 0.01% |
4,365
+1,279
| +41% | +$396K |
|
615
Occidental Petroleum
OXY
$54.6B
| $1.58M | 0.01% |
50,421
-134,663
| -73% | -$3.61M |
|
616
CenterPoint Energy
CNP
$28.8B
| $1.57M | 0.01% |
63,910
+3,562
| +6% | +$87.4K |
|
617
Nautilus Biotechnolgy
NAUT
$211M
| $1.57M | 0.01% |
+155,000
| New | +$1.68M |
|
618
Essex Property Trust
ESS
$18.7B
| $1.56M | 0.01% |
5,202
-920
| -15% | -$271K |
|
619
Organon & Co
OGN
$3.56B
| $1.55M | 0.01% |
+51,274
| New | +$1.69M |
|
620
Cardinal Health
CAH
$53.7B
| $1.55M | 0.01% |
27,150
-20,629
| -43% | -$1.21M |
|
621
Archer Daniels Midland
ADM
$40.1B
| $1.53M | 0.01% |
25,308
-15,755
| -38% | -$1M |
|
622
Five Below
FIVE
$11.5B
| $1.53M | 0.01% |
+7,922
| New | +$1.51M |
|
|
SOLY
623
DELISTED
Soliton, Inc.
SOLY
| $1.52M | 0.01% |
+67,770
| New | +$1.37M |
|
624
ZTO Express
ZTO
$18.1B
| $1.52M | 0.01% |
50,000
-17,199
| -26% | -$531K |
|
625
Fortinet
FTNT
$112B
| $1.49M | 0.01% |
31,365
-559,670
| -95% | -$23.9M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.